132 related articles for article (PubMed ID: 9221383)
1. [Pleurodesis in malignant pleural effusion: bleomycin vs. mitoxantrone].
Schmidt M; Schaarschmidt G; Chemaissani A
Pneumologie; 1997 Apr; 51(4):367-72. PubMed ID: 9221383
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin in malignant pleural effusion. Choose talc pleurodesis.
Prescrire Int; 2011 Dec; 20(122):291. PubMed ID: 22216541
[TBL] [Abstract][Full Text] [Related]
3. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
4. [Current treatment strategy in malignant pleural effusion].
Türler A; Walter M; Schmitz-Rixen T
Wien Klin Wochenschr; 1996; 108(9):255-61. PubMed ID: 8686317
[TBL] [Abstract][Full Text] [Related]
5. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis.
Sioris T; Sihvo E; Salo J; Räsänen J; Knuuttila A
Eur J Surg Oncol; 2009 May; 35(5):546-51. PubMed ID: 18644696
[TBL] [Abstract][Full Text] [Related]
6. Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer.
Barbetakis N; Antoniadis T; Tsilikas C
World J Surg Oncol; 2004 May; 2():16. PubMed ID: 15153245
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube.
Caglayan B; Torun E; Turan D; Fidan A; Gemici C; Sarac G; Salepci B; Kiral N
Ann Surg Oncol; 2008 Sep; 15(9):2594-9. PubMed ID: 18594928
[TBL] [Abstract][Full Text] [Related]
8. Malignant pleural effusion treatment outcomes: pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomy.
Luh SP; Chen CY; Tzao CY
Thorac Cardiovasc Surg; 2006 Aug; 54(5):332-6. PubMed ID: 16902882
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
10. Primary treatment of malignant pleural effusions: video-assisted thoracoscopic surgery poudrage versus tube thoracostomy.
Erickson KV; Yost M; Bynoe R; Almond C; Nottingham J
Am Surg; 2002 Nov; 68(11):955-9; discussion 959-60. PubMed ID: 12455787
[TBL] [Abstract][Full Text] [Related]
11. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms.
Kelly-Garcia J; Roman-Berumen JF; Ibarra-Perez C
Arch Med Res; 1997; 28(4):583-5. PubMed ID: 9428588
[TBL] [Abstract][Full Text] [Related]
12. Rapid pleurodesis in symptomatic malignant pleural effusion.
Yildirim E; Dural K; Yazkan R; Zengin N; Yildirim D; Gunal N; Sakinci U
Eur J Cardiothorac Surg; 2005 Jan; 27(1):19-22. PubMed ID: 15621465
[TBL] [Abstract][Full Text] [Related]
13. Povidone-iodine and bleomycin in the management of malignant pleural effusion.
Alavi AA; Eshraghi M; Rahim MB; Meysami AP; Morteza A; Hajian H
Acta Med Iran; 2011; 49(9):584-7. PubMed ID: 22052141
[TBL] [Abstract][Full Text] [Related]
14. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
Sartori S; Tassinari D; Ceccotti P; Tombesi P; Nielsen I; Trevisani L; Abbasciano V
J Clin Oncol; 2004 Apr; 22(7):1228-33. PubMed ID: 15051770
[TBL] [Abstract][Full Text] [Related]
16. Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drug.
Ukale V; Agrenius V; Hillerdal G; Mohlkert D; Widström O
Lung Cancer; 2004 Mar; 43(3):323-8. PubMed ID: 15165091
[TBL] [Abstract][Full Text] [Related]
17. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
[TBL] [Abstract][Full Text] [Related]
18. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY
Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593
[TBL] [Abstract][Full Text] [Related]
19. [The effect of intrapleural pingyangmycin administration on activity of fibrinolytic system and transforming growth factor-beta1 in malignant pleural effusion].
Zhu QQ; Sun GY
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):674-8. PubMed ID: 20079281
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to gynecological cancer.
Cheng D; Chan YM; Ng TY; Cheung AN; Ngan HY; Wong LC
Acta Obstet Gynecol Scand; 1999 May; 78(5):443-6. PubMed ID: 10326892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
